文献速递其他结缔组织病

抗磷脂抗体在系统性硬化症中的临床相关性:系统综述与荟萃分析

Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2016-10-13

该系统综述与荟萃分析检索了1983年1月至2016年7月EMBASE和PubMed数据库,评估抗磷脂抗体(aPL)在系统性硬化症(SSc)中的临床相关性。结果显示SSc患者IgG/IgM抗心磷脂抗体(aCL)和抗β2糖蛋白I抗体(aβ2GPI)阳性率均高于对照,且aCL阳性与肺动脉高压(PAH)、肾脏疾病、血栓形成和指端梗死/缺血风险升高相关。

要点

  • SSc患者IgG/IgM aCL和aβ2GPI阳性率均显著高于对照人群
  • aCL(IgG/IgM合并)阳性SSc患者PAH患病率高于阴性患者
  • IgG aCL、IgM aCL和IgM aβ2GPI阳性与血栓形成患病率升高相关

核心结论

  • IgG/IgM型aCL和aβ2GPI与SSc存在强关联,阳性患者更易出现PAH、肾脏疾病、血栓形成和指端梗死/缺血。

研究设计与样本

  • 遵循PRISMA指南系统检索EMBASE和PubMed数据库1983年1月至2016年7月文献,采用Peto比值比(OR)对罕见事件进行荟萃分析。

主要发现

  • SSc患者IgG aCL阳性率12.8% vs 对照1.6%,IgM aCL阳性率7.8% vs 0.6%,两者p均<0.0001。
  • SSc患者IgG aβ2GPI阳性率6.1% vs 对照0.58%(p<0.0001),IgM aβ2GPI阳性率3.5% vs 0.3%(p=0.001)。
  • aCL(IgG/IgM合并)阳性SSc患者PAH患病率26.5% vs 阴性10.9%(p<0.0001)。
  • IgG aCL阳性SSc患者肾脏疾病患病率36.3% vs 阴性10.9%(p=0.02)。
  • 血栓形成患病率在IgG aCL阳性vs阴性为12.6% vs 1.4%(p<0.0001),IgM aCL为15.1% vs 2.7%(p=0.002),IgM aβ2GPI为15% vs 0.78%(p=0.009)。

临床怎么用

  • 对SSc患者检测IgG/IgM型aCL和aβ2GPI可能有助于识别PAH、肾脏疾病、血栓形成和指端梗死/缺血高风险者。

局限性

  • 数据以aPL阳性患者频率而非平均抗体滴度表示,限制了对上述关联的进一步解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the clinical relevance of antiphospholipid antibodies (aPL) in systemic sclerosis (SSc). METHODS: A systematic search of EMBASE and PubMed databases from January 1983 to July 2016 was carried out according to PRISMA guidelines whereas Peto׳s odds ratio (OR) for rare events was used for the meta-analysis. RESULTS: The pooled prevalence of participants positive for IgG and IgM anticardiolipin (aCL) antibodies was higher in SSc than controls (12.8% vs 1.6% and 7.8% vs 0.6%; p < 0.0001 for both) as was that of IgG and IgM anti-beta-2-glycoprotein-I antibodies (aβ2GPI) (6.1% vs 0.58%, p < 0.0001; 3.5% vs 0.3%, p = 0.001). The pooled prevalence of pulmonary arterial hypertension (PAH) was more common in SSc positive than negative patients for aCL (IgG/IgM combined) (26.5% vs 10.9%, p < 0.0001) whereas the pooled prevalence of renal disease (RD) was more common in IgG aCL positive than negative patients (36.3% vs 10.9%, p = 0.02). The pooled prevalence of thrombosis was higher in IgG aCL, IgM aCL, and IgM aβ2GPI positive than negative SSc patients (12.6% vs 1.4%, p < 0.0001), (15.1% vs 2.7%, p = 0.002) and (15% vs 0.78%, p = 0.009), respectively. The pooled prevalence of digital infarction/ischemia (DI) was higher in IgG aCL and IgM positive than negative SSc (52.8% vs 39.8%, p = 0.002) and (68.1% vs 29%, p = 0.07). CONCLUSIONS: A strong relationship exists between aCL and aβ2GPI of IgG/IgM isotype and SSc; patients positive for these antibodies are more likely to suffer from PAH, RD, thrombosis, and DI. However, data expressed as frequency of aPL positive patients rather than average antibody titers preclude further insight into the relevance of these assumptions.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Merashli M, Alves J, Ames PRJ, et al. Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2016. PMID: 27838012. doi:10.1016/j.semarthrit.2016.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。